https://scholars.lib.ntu.edu.tw/handle/123456789/623271| Title: | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Authors: | Teng, Wei Chang, Ting-Tsung Yang, Hwai-I Peng, Cheng-Yuan Su, Chien-Wei TUNG-HUNG SU Hu, Tsung-Hui Yu, Ming-Lung Yang, Hung-Chih Wu, Jaw-Ching |
Keywords: | Antiviral therapy; Benefits; Family history; Gray zone; Hepatitis B virus; Hepatocellular carcinoma; Noncirrhosis; prediction; Risk score; Treatment guidelines | Issue Date: | Dec-2021 | Publisher: | SPRINGER | Journal Volume: | 15 | Journal Issue: | 6 | Start page/Pages: | 1421 | Source: | Hepatology international | Abstract: | ALT ≥ 80 U/L and HBV DNA ≥ 2000 IU/ml are treatment criteria of APASL guidelines for chronic hepatitis B (CHB) patients. The need of antiviral therapy for patients in gray zone (ALT < 80 U/L or HBV DNA < 2000 IU/ml) is controversial. This study aimed to develop a scoring system to predict hepatocellular carcinoma (HCC) and evaluate the benefit of antiviral therapy in these patients. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/623271 | ISSN: | 1936-0533 | DOI: | 10.1007/s12072-021-10263-x |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.